Literature DB >> 19448649

Nicotine and inflammatory neurological disorders.

Wen-Hua Piao1, Denise Campagnolo, Carlos Dayao, Ronald J Lukas, Jie Wu, Fu-Dong Shi.   

Abstract

Cigarette smoke is a major health risk factor which significantly increases the incidence of diseases including lung cancer and respiratory infections. However, there is increasing evidence that smokers have a lower incidence of some inflammatory and neurodegenerative diseases. Nicotine is the main immunosuppressive constituent of cigarette smoke, which inhibits both the innate and adaptive immune responses. Unlike cigarette smoke, nicotine is not yet considered to be a carcinogen and may, in fact, have therapeutic potential as a neuroprotective and anti-inflammatory agent. This review provides a synopsis summarizing the effects of nicotine on the immune system and its (nicotine) influences on various neurological diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19448649      PMCID: PMC4002379          DOI: 10.1038/aps.2009.67

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  116 in total

Review 1.  Effects of cigarette smoke on the immune system.

Authors:  Mohan Sopori
Journal:  Nat Rev Immunol       Date:  2002-05       Impact factor: 53.106

2.  A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease.

Authors:  Miguel A Hernán; Bahi Takkouche; Francisco Caamaño-Isorna; Juan J Gestal-Otero
Journal:  Ann Neurol       Date:  2002-09       Impact factor: 10.422

3.  Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction.

Authors:  E R Matarredona; M Santiago; J L Venero; J Cano; A Machado
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

Review 4.  Nicotine and nicotinic receptors; relevance to Parkinson's disease.

Authors:  Maryka Quik; Jennifer M Kulak
Journal:  Neurotoxicology       Date:  2002-10       Impact factor: 4.294

Review 5.  Nicotine's oxidative and antioxidant properties in CNS.

Authors:  Mary B Newman; Gary W Arendash; R Douglas Shytle; Paula C Bickford; Thomas Tighe; Paul R Sanberg
Journal:  Life Sci       Date:  2002-11-01       Impact factor: 5.037

Review 6.  Medical therapy for ulcerative colitis.

Authors:  Niraj Jani; Miguel D Regueiro
Journal:  Gastroenterol Clin North Am       Date:  2002-03       Impact factor: 3.806

7.  Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease.

Authors:  Ramón Soto-Otero; Estefanía Méndez-Alvarez; Alvaro Hermida-Ameijeiras; Ana María López-Real; José Luis Labandeira-García
Journal:  Biochem Pharmacol       Date:  2002-07-01       Impact factor: 5.858

Review 8.  The nicotinic acetylcholine receptor, smoking, and Alzheimer's disease.

Authors:  Marwan N Sabbagh; Ronald J Lukas; D Larry Sparks; Richard T Reid
Journal:  J Alzheimers Dis       Date:  2002-08       Impact factor: 4.472

9.  Nicotine lowers the secretion of the Alzheimer's amyloid beta-protein precursor that contains amyloid beta-peptide in rat.

Authors:  Tadanobu Utsuki; Mohammed Shoaib; Harold W Holloway; Donald K Ingram; William C Wallace; Vahram Haroutunian; Kumar Sambamurti; Debomoy K Lahiri; Nigel H Greig
Journal:  J Alzheimers Dis       Date:  2002-10       Impact factor: 4.472

10.  Effects of nicotine exposure on T cell development in fetal thymus organ culture: arrest of T cell maturation.

Authors:  Aaron J Middlebrook; Cherie Martina; Yung Chang; Ronald J Lukas; Dominick DeLuca
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

View more
  42 in total

1.  Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [11C]DAA1106 Positron Emission Tomography Study.

Authors:  Arthur L Brody; Robert Hubert; Ryutaro Enoki; Lizette Y Garcia; Michael S Mamoun; Kyoji Okita; Edythe D London; Erika L Nurmi; Lauren C Seaman; Mark A Mandelkern
Journal:  Neuropsychopharmacology       Date:  2017-03-06       Impact factor: 7.853

Review 2.  Modeling drug exposure in rodents using e-cigarettes and other electronic nicotine delivery systems.

Authors:  Cristina Miliano; E Reilly Scott; Laura B Murdaugh; Emma R Gnatowski; Christine L Faunce; Megan S Anderson; Malissa M Reyes; Ann M Gregus; Matthew W Buczynski
Journal:  J Neurosci Methods       Date:  2019-10-12       Impact factor: 2.390

Review 3.  Modulatory Effects of Nicotine on neuroHIV/neuroAIDS.

Authors:  Haijun Han; Zhongli Yang; Sulie L Chang; Ming D Li
Journal:  J Neuroimmune Pharmacol       Date:  2018-09-13       Impact factor: 4.147

4.  Novel multifunctional pharmacology of lobinaline, the major alkaloid from Lobelia cardinalis.

Authors:  Dustin P Brown; Dennis T Rogers; Francois Pomerleau; Kirin B Siripurapu; Manish Kulshrestha; Greg A Gerhardt; John M Littleton
Journal:  Fitoterapia       Date:  2016-04-20       Impact factor: 2.882

5.  The effect of cigarette smoke exposure on spinal cord injury in rats.

Authors:  Zhong-kai Fan; Yang Cao; Gang Lv; Yan-song Wang; Zhan-peng Guo
Journal:  J Neurotrauma       Date:  2013-04-03       Impact factor: 5.269

Review 6.  Neuroinflammation, neurodegeneration, and depression.

Authors:  Laura L Hurley; Yousef Tizabi
Journal:  Neurotox Res       Date:  2012-08-16       Impact factor: 3.911

Review 7.  Heteromeric α7β2 Nicotinic Acetylcholine Receptors in the Brain.

Authors:  Jie Wu; Qiang Liu; Pei Tang; Jens D Mikkelsen; Jianxin Shen; Paul Whiteaker; Jerrel L Yakel
Journal:  Trends Pharmacol Sci       Date:  2016-05-11       Impact factor: 14.819

8.  Attenuation of CNS inflammatory responses by nicotine involves α7 and non-α7 nicotinic receptors.

Authors:  Junwei Hao; Alain R Simard; Gregory H Turner; Jie Wu; Paul Whiteaker; Ronald J Lukas; Fu-Dong Shi
Journal:  Exp Neurol       Date:  2010-10-13       Impact factor: 5.330

Review 9.  Duality of Antidepressants and Neuroprotectants.

Authors:  Yousef Tizabi
Journal:  Neurotox Res       Date:  2015-11-27       Impact factor: 3.911

10.  Characteristics of Critically Ill Patients with COVID-19 Compared to Patients with Influenza-A Single Center Experience.

Authors:  Frank Herbstreit; Marvin Overbeck; Marc Moritz Berger; Annabell Skarabis; Thorsten Brenner; Karsten Schmidt
Journal:  J Clin Med       Date:  2021-05-11       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.